Walden Catalyst

Walden Catalyst Ventures is a venture capital firm focused on early-stage deep-tech investments across the United States, Europe, and Israel. The firm targets disruptive technologies in sectors such as artificial intelligence, cloud infrastructure, data analytics, semiconductors, and digital biology (TechBio). Founded in 2021 by technology veterans Lip-Bu Tan and Young Sohn, Walden Catalyst manages a $550 million inaugural fund aimed at supporting startups at the intersection of science and engineering. In the life sciences and healthcare sectors, the firm specifically invests in companies that leverage computational power and AI to transform drug discovery and clinical diagnostics, with notable portfolio companies including Peptone and Artera.